Correlation Between Lyra Therapeutics and Johnson Johnson

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Johnson Johnson, you can compare the effects of market volatilities on Lyra Therapeutics and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Johnson Johnson.

Diversification Opportunities for Lyra Therapeutics and Johnson Johnson

0.7

Correlation Coefficient

Lyra Therapeutics  Johnson Johnson

Poor diversification

The 3 months correlation between Lyra and Johnson is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Johnson Johnson go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Johnson Johnson

Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 5.4 times more return on investment than Johnson Johnson. However, Lyra Therapeutics is 5.4 times more volatile than Johnson Johnson. It trades about -0.03 of its potential returns per unit of risk. Johnson Johnson is currently generating about -0.33 per unit of risk. If you would invest  19.00  in Lyra Therapeutics on September 24, 2024 and sell it today you would lose (1.00) from holding Lyra Therapeutics or give up 5.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Johnson Johnson

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Johnson Johnson

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the company stakeholders.

Pair Trading with Lyra Therapeutics and Johnson Johnson

The main advantage of trading using opposite Lyra Therapeutics and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.

The idea behind Lyra Therapeutics and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.